HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCCNFP Updates Fragrance Materials Prohibited In Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

The European Union's Scientific Committee on Cosmetics and Non-Food Products has added a number of fragrance ingredients to a list of perfumery materials prohibited in cosmetics without restrictions. The SCCNFP opinions were adopted during a plenary meeting Dec. 9 and incorporated into a recently released report

You may also be interested in...



Diethyl Phthalate Safety In Cosmetics Reconfirmed By SCCNFP

The Scientific Committee on Cosmetics and Non-Food Products, an advisory panel to the European Commission, says in a recent opinion it will not change its safety assessment for diethyl phthalate in cosmetics following the review of new data

Diethyl Phthalate Safety In Cosmetics Reconfirmed By SCCNFP

The Scientific Committee on Cosmetics and Non-Food Products, an advisory panel to the European Commission, says in a recent opinion it will not change its safety assessment for diethyl phthalate in cosmetics following the review of new data

Bergamottin Cosmetics Ban Reaffirmed In SCCNFP Opinion

Inadequate safety data exist on the phototoxic potential of bergamottin to permit the perfumery material's use in cosmetics without restrictions, the European Union Scientific Committee on Cosmetic Products and Non-Food Products concludes in a recently released 1opinion

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011872

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel